| 7/29/2015 | BKCVHY | S&P upgrades Salix
|
| 4/6/2015 | CAHYLM | Salix Pharmaceuticals sets redemption price for $262 million 6% notes
|
| 4/1/2015 | CAHYLM | Valeant to redeem Salix’s 6% senior notes due 2021 in two stages
|
| 3/19/2015 | HY | Market Commentary: Rite Aid, Sensata price deals; new Rite Aid rises; Guitar Center gains; funds lose $1 billion
|
| 3/12/2015 | HY | Market Commentary: United Rentals, CenturyLink, Reliance deals price; Valeant upsizes; funds lose $1.96 billion
|
| 3/11/2015 | HY | Market Commentary: Shea Homes two-parter, Surgical Care, GFL deals price; Valeant up on Endo bid for Salix
|
| 3/9/2015 | HY | Market Commentary: Crestwood, Masonite, HealthSouth drive by; calendar builds massively; Whiting jumps on sale talk
|
| 2/24/2015 | HY | Market Commentary: Digicel drives by, moves up; recent bonds busy; Sitel bonds gain as Onex eyes possible sale
|
| 2/23/2015 | HY | Market Commentary: DISH weakens after numbers, CEO retirement; Salix gains on Valeant merger; Toys’ bonds push up
|
| 2/23/2015 | BKCVHY | Moody’s could raise Salix
|
| 11/7/2014 | CLHY | Market Commentary: Salix slides with onslaught of negative news; Southeast PowerGen, Essar, US LBM break
|
| 11/7/2014 | BKCVHY | Moody’s reviews Salix
|
| 11/7/2014 | BKCVHY | S&P lowers Salix, debt
|
| 11/6/2014 | HY | Market Commentary: Molycorp bonds mauled on poor earnings; Cliffs clobbered too; hard-hit Aegerion comes back
|
| 12/12/2013 | HY | Market Commentary: Salix, Walter, Arch lead $2.44 billion session; existing Arch bonds up; funds gain $16 million
|
| 12/12/2013 | HY | New Issue: Salix prices $750 million seven-year notes at par to yield 6%
|
| 12/11/2013 | HY | Market Commentary: Endo, Digicel, Ashtead drive-bys dominate $1.9 billion primary session; new Sprint hanging in
|
| 12/11/2013 | HY | Salix Pharmaceuticals talks $750 million seven-year notes to yield 6%-61/4%; pricing Thursday
|
| 12/6/2013 | HY | Market Commentary: Upsized Ultra Petroleum, Abengoa deals pace busy session, cap $10.5 billion week
|
| 12/6/2013 | HY | Salix Pharmaceuticals sets Monday roadshow start for $750 million seven-year notes via Jefferies
|
| 12/3/2013 | HY | Salix expected to start roadshow on Monday for $750 million senior notes via Jefferies
|
| 12/2/2013 | BKCVHY | Moody's rates Salix loans Ba1, notes B2
|
| 12/2/2013 | BKCVHY | S&P assigns BB to Salix loan, gives B to notes
|
| 11/18/2013 | BKHY | Salix plans $1.35 billion credit facility, $750 million notes
|
| 11/8/2013 | BKHY | Salix plans $1.95 billion of new financing, $150 million revolver
|
